158 related articles for article (PubMed ID: 1102659)
1. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
Heman-Ackah SM
J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
[TBL] [Abstract][Full Text] [Related]
2. Microbial kinetics of drug action against gram-positive and gram-negative organisms. II: Effect of clindamycin on Staphylococcus aureus and Escherichia coli.
Heman-Ackah SM
J Pharm Sci; 1975 Oct; 64(10):1612-20. PubMed ID: 241826
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
Bassler M; Just HM; Richter A; Zeller H; Daschner F
Infection; 1984; 12(4):280-5. PubMed ID: 6490174
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and mechanisms of drug action on microorganisms. 13. Comparative studies on action of lincomycin, clindamycin, and U 24729A against Escherichia coli.
Heman-Ackah SM; Garrett ER
J Med Chem; 1972 Feb; 15(2):152-63. PubMed ID: 4550331
[No Abstract] [Full Text] [Related]
5. Microbial kinetics of drug action against gram-positive and gram-negative organisms. I. Effect of lincomycin on Staphylococcus aureus and Escherichia coli.
Heman-Ackah SM
J Pharm Sci; 1974 Jul; 63(7):1077-84. PubMed ID: 4604772
[No Abstract] [Full Text] [Related]
6. Comparison of tetracycline action on Staphylococcus aureus and Escherichia coli by microbial kinetics.
Heman-Ackah SM
Antimicrob Agents Chemother; 1976 Aug; 10(2):223-8. PubMed ID: 791094
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and mechanisms of action of drugs on microorganisms. XV. Effect of erythromycin on the action of lincomycin (Phase II) and the 7 (S)-chloro analogs of lincomycin against Escherichia coli.
Heman-Ackah SM; Garrett ER
J Pharm Sci; 1972 Apr; 61(4):545-51. PubMed ID: 4552281
[No Abstract] [Full Text] [Related]
8. Kinetics and mechanisms of action of drugs on microorganisms. XVI. Effect of oleandomycin and its combinations with tetracycline, chloramphenicol, erythromycin, lincomycin, and 1'-demethyl-4'-depropyl-4'-(R and S)-n-pentylclindamycin on microbial generation of Escherichia coli.
Won CM; Garrett ER
J Pharm Sci; 1973 Jul; 62(7):1087-92. PubMed ID: 4576800
[No Abstract] [Full Text] [Related]
9. Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
Barcs I
J Chemother; 1993 Aug; 5(4):215-22. PubMed ID: 8229148
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake of clindamycin and lincomycin.
Easmon CS; Crane JP
Br J Exp Pathol; 1984 Dec; 65(6):725-30. PubMed ID: 6498086
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin therapy of Staphylococcus aureus endocarditis. Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin.
Watanakunakorn C
Am J Med; 1976 Mar; 60(3):419-25. PubMed ID: 1045861
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.
Leclercq R; Carlier C; Duval J; Courvalin P
Antimicrob Agents Chemother; 1985 Sep; 28(3):421-4. PubMed ID: 3907492
[TBL] [Abstract][Full Text] [Related]
13. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
Wiedemann B
Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
[No Abstract] [Full Text] [Related]
14. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
Jakubicz P; Dzierzanowska D
Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
[No Abstract] [Full Text] [Related]
15. Susceptibility of bacteria to serum lysis or phagocytosis following growth in subinhibitory levels of lincosaminide or spectinomycin related antibiotics.
Cialdella JI; Vavra JJ; Marshall VP
J Antibiot (Tokyo); 1986 Jul; 39(7):978-84. PubMed ID: 2944862
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA.
Douthwaite S
Nucleic Acids Res; 1992 Sep; 20(18):4717-20. PubMed ID: 1383931
[TBL] [Abstract][Full Text] [Related]
17. Lincomycin, clindamycin and their applications.
Spízek J; Rezanka T
Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701
[TBL] [Abstract][Full Text] [Related]
18. Effect of novobiocin and its combination with tetracycline, chloramphenicol, erythromycin, and lincomycin on the microbial generation of Escherichia coli.
Garrett ER; Won CM
Antimicrob Agents Chemother; 1973 Dec; 4(6):626-33. PubMed ID: 4602829
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of clindamycin and lincomycin on end-plate currents and quantal content at the neuromuscular junction.
Fiekers JF; Henderson F; Marshall IG; Parsons RL
J Pharmacol Exp Ther; 1983 Nov; 227(2):308-15. PubMed ID: 6313896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
